By InvitationNot Applicable

Physiotherapy After Breast Reduction Surgery

Turkey (Türkiye)40 participantsStarted 2026-07-23

Plain-language summary

Background and Purpose: Breast reduction surgery is a major procedure that can lead to post-operative pain, postural deviations, and a temporary decline in quality of life.This clinical study aims to investigate the efficacy of early-phase physical therapy on pain management, postural alignment, and overall quality of life in female patients following breast reduction surgery. Study Design and Participants: This is a controlled clinical trial involving 40 female participants aged 18 to 50 who have undergone their first breast reduction surgery. Participants are divided into two groups: an intervention group (n=20) and a control group (n=20). The study follows a pre-test and post-test design to evaluate outcomes before and after a three-week intervention period. Intervention Protocol: The intervention group receives a comprehensive physical therapy program starting one week post-operation. The program is conducted three days a week for three weeks, with sessions lasting 40 to 60 minutes The protocol includes: Postural and cervical exercises Scapular stabilization and manual therapy Scar massage and Transcutaneous Electrical Nerve Stimulation (TENS) as needed A structured home exercise program. Outcome Measures: Primary and secondary outcomes are assessed through various clinical tools: Pain:Visual Analog Scale (VAS) Posture: New York Posture Test, measurements of scapular protraction and cervical anterior tilt Mobility:Shoulder and cervical Range of Motion (ROM) Quality of Life and Health: SF-12, BREAST-Q, and Pittsburgh Sleep Quality Index (PSQI) Expected Results: The study anticipates that the early-phase physical therapy group will demonstrate a significant reduction in pain, improved postural alignment, and a higher quality of life compared to the control group.

Who can participate

Age range

18 Years – 50 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

. Oncological History:
. Lymphovenous Disorders: Those with lymphedema in the upper extremity or vascular insufficiency that may severely affect lymphatic drainage,
. Musculoskeletal and Nervous System Pathologies: Those with orthopedic diseases such as severe scoliosis, ankylosing spondylitis, or neurological diseases such as brachial plexus lesions that may affect posture analysis and shoulder mobility,
. Systemic Diseases: Those with uncontrolled Diabetes Mellitus, which directly negatively affects wound healing, or those with active autoimmune connective tissue diseases,
. Exercise Contraindications: Patients with cardiopulmonary failure or severe cognitive impairment that would prevent participation in the physiotherapy protocol.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Breast-Q Reduction Module Score

Timeframe: Baseline (preoperative) and 4 weeks after treatment

Trial details

NCT IDNCT07729735

SponsorIstanbul Rumeli University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-10

View on ClinicalTrials.gov More Breast trials